GRCE
Grace Therapeutics, Inc. Common Stock
GRCE
GRCE
27 hedge funds and large institutions have $6.67M invested in Grace Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+14
Holders Change %
+107.69%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
1
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PP
Peconic Partners
New York
|
$662K |
| 2 |
Two Sigma Advisers
New York
|
$647K |
| 3 |
Renaissance Technologies
New York
|
$475K |
| 4 |
MFS
Monetta Financial Services
Wheaton,
Illinois
|
$189K |
| 5 |
OC
Oppenheimer & Co
New York
|
$104K |
